Ixazomib-thalidomide-dexamethasone as induction therapy in high-dose ineligible newly diagnosed Multiple myeloma patients; a phase 2 study

Abildgaard , N. (Underviser)

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode16. nov. 2017
BegivenhedstitelDMSG (Dansk Myelomatose Study Group). Scientific Symposium: Treatment of Multiple Myeloma - Standard of Care anno 2017
BegivenhedstypeKonference
PlaceringOdense, Danmark